Bamberger J D, Unick J, Klein P, Fraser M, Chesney M, Katz M H
San Francisco Department of Public Health, Calif. 94102, USA.
Am J Public Health. 2000 May;90(5):699-701. doi: 10.2105/ajph.90.5.699.
Recent studies have documented dramatic decreases in opportunistic infections, hospitalizations, and mortality among HIV-infected persons, owing primarily to the advent of highly active antiretroviral medications. Unfortunately, not all segments of the population living with HIV benefit equally from treatment. In San Francisco, only about 30% of the HIV-infected urban poor take combination highly active antiretroviral medications, as compared with 88% of HIV-infected gay men. Practitioners who care for the urban poor are reluctant to prescribe these medications, fearing inadequate or inconsistent adherence to the complicated medical regimen. Persons typically must take 2 to 15 pills at a time, 2 to 3 times a day. Some of the medications require refrigeration, which may not be available to the homeless poor. Most homeless persons do not have food available to them on a consistent schedule. Therefore, they may have difficulty adhering to instructions to take medications only on an empty stomach or with food. Lack of a safe place to store medications may be an issue for some. In addition, many urban poor live with drug, alcohol, or mental health problems, which can interfere with taking medications as prescribed. Inconsistent adherence to medication regimens has serious consequences. Patients do not benefit fully from treatments, and they will become resistant to the medications in their regimen as well as to other medications in the same classes as those in their regimen. Development of resistance has implications for the broader public health, because inadvertent transmission of multidrug-resistant strains of HIV has been demonstrated. Concern that the urban poor will not adhere to highly active antiretroviral medication regimens has led to debate on the role of clinicians and public health officials in determining who can comply with these regimens. Rather than define the characteristics that would predict adherence to these regimens, the San Francisco Department of Public Health created a program to support adherence among those who may have the greatest difficulty complying with complicated highly active antiretroviral medication regimens. The program, dubbed the Action Point Adherence Project, was conceived through a community planning process in preparation for a city-wide summit on HIV/AIDS that took place in January 1998. Action Point is funded by the city and the county of San Francisco. Now in its 10th month, the program continues to show promising evidence of improving clients' biological and social indicators.
近期研究表明,由于高效抗逆转录病毒药物的出现,艾滋病毒感染者的机会性感染、住院率和死亡率大幅下降。不幸的是,并非所有艾滋病毒感染者群体都能平等地从治疗中获益。在旧金山,只有约30%感染艾滋病毒的城市贫困人口服用联合高效抗逆转录病毒药物,而感染艾滋病毒的男同性恋者中这一比例为88%。照顾城市贫困人口的从业者不愿开这些药物,担心他们对复杂的治疗方案依从性不足或不一致。患者通常一次要服用2至15片药,一天服用2至3次。有些药物需要冷藏,而无家可归的贫困人口可能无法做到。大多数无家可归者无法按时获得食物。因此,他们可能难以遵照医嘱空腹或与食物一起服药。对一些人来说,缺乏安全的药物储存场所可能也是个问题。此外,许多城市贫困人口存在药物滥用、酗酒或心理健康问题,这可能会干扰他们按规定服药。对治疗方案依从性不一致会产生严重后果。患者无法充分从治疗中获益,而且他们会对治疗方案中的药物以及同一类别的其他药物产生耐药性。耐药性的出现对更广泛的公共卫生有影响,因为已经证实存在艾滋病毒多重耐药菌株的意外传播。担心城市贫困人口无法坚持高效抗逆转录病毒治疗方案引发了关于临床医生和公共卫生官员在确定谁能遵守这些方案方面作用的争论。旧金山公共卫生部没有去界定能预测对这些方案依从性的特征,而是设立了一个项目来支持那些在遵守复杂的高效抗逆转录病毒治疗方案方面可能最困难的人群的依从性。该项目名为“行动点依从性项目”,是通过一个社区规划过程构思出来的,为1998年1月举行的全市艾滋病毒/艾滋病峰会做准备。行动点项目由旧金山市和县资助。该项目开展到第10个月时,继续显示出改善客户生物学和社会指标的良好迹象。